Private Equity Interest in Women’s Health
Kearney’s Paula Bellostas Muguerza discussed trends driving private equity dealmakers to the women’s health sector, citing a $1 trillion gap as a key factor, according to PE Hub. This involves private equity firms focusing on opportunities in women’s health due to identified market needs. Astorg, Cinven, and Nordic are targeting pathology assets, as noted in the same report.
Deals in the Pathology Sector
The article examines deals in the pathology sector and the tailwinds behind them, with Astorg, Cinven, and Nordic specifically pursuing these assets. These developments reflect broader interest in healthcare subsectors, according to PE Hub. Paula Bellostas Muguerza from Kearney provided insights into how such trends are shaping private equity strategies.
The EyeSouth Partners Sale
The $1.1 billion sale of EyeSouth Partners to Cencora was discussed as part of healthcare deal activity. This transaction highlights growth in the sector under Olympus Partners’ ownership, according to PE Hub. It connects to the overall narrative of private equity’s expanding role in healthcare.
Growth and Tailwinds in Healthcare
The business of EyeSouth Partners experienced growth while under Olympus Partners, contributing to its appeal in private equity circles. Tailwinds in the pathology sector are driving further investments, as outlined in the PE Hub article.
